KA Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 geg. 2024 @ 23:00):

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners...

Stats
Dzisiejszy wolumen	292 533
Średni wolumen	392 022
Kapitalizacja rynkowa	7.09M
EPS	$0 ( 2024-03-29 )
Następna data zysków	( $-0.210 ) 2024-06-06
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.490
ATR14	$0.00700 (1.12%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Bartoszek Raymond J.	Buy	903 995	Common Stock
2024-04-14	Iadonato Shawn	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Philips Craig W.	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Baker Keith	Buy	225 000	Stock Option (Right to Buy)
2024-04-14	Guillaudeux Thierry	Buy	225 000	Stock Option (Right to Buy)

INSIDER POWER
95.43
Last 64 transactions
Buy: 2 929 101 \| Sell: 94 301

Wolumen Korelacja

Długi: 0.04 (neutral)

Krótki: -0.58 (weak negative)

Signal:(49.554) Neutral

Kineta, Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kineta, Inc. Korelacja - Waluta/Towar

0.62
( weak )

0.76
( moderate )

0.00
( neutral )

0.70
( moderate )

-0.73
( moderate negative )

-0.07
( neutral )

Kineta, Inc. Finanse

Annual	2023
Przychody:	$5.44M
Zysk brutto:	$5.43M (99.83 %)
EPS:	$-1.280

FY	2023
Przychody:	$5.44M
Zysk brutto:	$5.43M (99.83 %)
EPS:	$-1.280

FY	2022
Przychody:	$1.95M
Zysk brutto:	$1.22M (62.42 %)
EPS:	$-12.80

FY	2021
Przychody:	$9.09M
Zysk brutto:	$0.00 (0.00 %)
EPS:	$-0.152

Financial Reports:

No articles found.

Kineta, Inc.

Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.